Byrna Technologies Inc. Share Price Canadian Securities Exchange

Equities

BYRN

US12448X2018

Aerospace & Defense

Delayed Canadian Securities Exchange 5-day change 1st Jan Change
- CAD -.--% Intraday chart for Byrna Technologies Inc. -.--% -.--%

Financials

Sales 2024 * 74.18M 102M 5.73B Sales 2025 * 88.22M 121M 6.81B Capitalization 238M 326M 18.38B
Net income 2024 * - 0 0 Net income 2025 * 5M 6.84M 386M EV / Sales 2024 * 3.21 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 2.7 x
P/E ratio 2024 *
-523 x
P/E ratio 2025 *
39.4 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 71.71%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 66 20/07/16
Director of Finance/CFO 59 31/07/20
Chief Tech/Sci/R&D Officer - 31/12/17
Members of the board TitleAgeSince
Chief Executive Officer 66 20/07/16
Director/Board Member 72 01/12/21
Chairman 64 08/07/19
More insiders
Byrna Technologies Inc. is a technology company. The Company specializing in the development, manufacture, and sale of advanced less-lethal personal security solutions. The Company's product portfolio includes handheld personal security devices and shoulder-fired launchers designed for use by consumers and professional security customers; a line of projectiles that are fired by Byrna devices, including chemical irritants, kinetic and inert rounds; a line of self-defense aerosol products, including Byrna Bad Guy Repellent, and accessories and related safety products, including the Byrna Banshee, Byrna Shield, compressed carbon dioxide (CO2) canisters, sighting systems, holsters and Byrna-branded apparel. Its flagship product, the Byrna SD, is a compact, ergonomically designed, handheld personal security device with the size and form factor of a compact handgun. It is easy to use, has virtually no recoil and is designed to fire accurately with an effective range of 50 feet.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
10.45 USD
Average target price
18.12 USD
Spread / Average Target
+73.44%
Consensus